ERDERA Joint Transnational Call 2025 "Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation"

Due: Feb 12, 2025

Description

The ERDERA Joint Transnational Call 2025 focuses on "Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation." This call is for research consortia interested in submitting transnational project proposals for the development and validation of pre-clinical therapies for rare diseases. The aim is to address unmet needs in this field and move from scientific ideas and preliminary results to potential clinical applications. The call emphasizes transnational collaboration, invol...

Estimated Total Program Funding$32,625,162

Eligible Applicants- Organization- Early Career Professor- Senior Researcher- Academic Institution

Additional Eligibility Information

Research consortia involving at least two independent legal entities from two different EU Member States or Horizon Europe associated countries are eligible. Each consortium must involve four to six eligible principal investigator partners from at least four different participating countries. For other eligibility criteria, see https://funding.erdera.org/.

Funding TypegrantCategories of Funding Activity- Rare Diseases Research- Pre-clinical Therapy Studies- Small Molecules and Biologicals

Grantor Contact Informationhttps://commission.europa.eu/about-european-commission/contact_enGrantor Emailselteneerkrankungen@dlr.deOther Grantor InformationThe European Commission is the EU's main executive body, serving as a crucial institution of the European Union. It plays a pivotal role in proposing legislation, upholding EU treaties, and ensuring that Member States apply EU law and policies. The Commission is responsible for managing the EU's budget and negotiating international agreements on behalf of the European Union. Led by President Ursula von der Leyen for the 2024-2029 mandate, the Commission consists of 27 Commissioners, each tasked with specific policy priorities. Its primary functions include developing EU strategy, translating policies into concrete initiatives, and working across various domains such as competitiveness, security, social fairness, quality of life, democracy, and global engagement. The Commission acts as a key driver of European integration, working to build a sustainable, digital, and inclusive future for EU citizens, businesses, and stakeholders.

Additional InformationThe project is part of the European Rare Diseases Research Alliance (ERDERA), aiming to advance pre-clinical therapy studies for rare diseases by overcoming geographic and knowledge barriers through international collaboration. It builds upon previous projects and aims to include patient perspectives and ethical considerations in the research process. Additional URLs:

https://webgate.ec.europa.eu/funding-tenders-opportunities/display/OM/Online+Manual

https://culture.ec.europa.eu/resources/creative-europe-desks

https://funding.erdera.org/

Supporting Linkhttps://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/competitive-calls-cs/9515?isExactMatch=true&status=31094501,31094502&order=DESC&pageNumber=2&pageSize=50&sortBy=startDate

Start finding grants with Atom for

$0 today

$30 Billed monthly after 7-day trial. Cancel anytime.

Personalized grant emails delivered weekly, right to your inbox.

AI powered search engine with both keyword and semantic search capabilities.

Grant filters to find the perfect funding opportunities.

Similar Grants

Eligibility

Profile

Finance

Other

Similar Grants

ERDERA Joint Transnational Call 2025 "Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation"

Start finding grants with Atom for

$0 today

$30 Billed monthly after 7-day trial. Cancel anytime.

Personalized grant emails delivered weekly, right to your inbox.

AI powered search engine with both keyword and semantic search capabilities.

Grant filters to find the perfect funding opportunities.

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

Notice of Intent to Publish the re-issuance of the Notice of Funding Opportunity (NOFO) Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

ERDERA Joint Transnational Call 2025 "Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation"

Start finding grants with Atom for

$0 today

$30 Billed monthly after 7-day trial. Cancel anytime.

Personalized grant emails delivered weekly, right to your inbox.

AI powered search engine with both keyword and semantic search capabilities.

Grant filters to find the perfect funding opportunities.

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

Notice of Intent to Publish the re-issuance of the Notice of Funding Opportunity (NOFO) Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)